Spruce Biosciences, Inc. (SPRB) Q4 2024 Earnings
SPRB·Reported April 2, 2025·Before market open
Spruce Biosciences, Inc. reported Q4 2024 revenue of $697.0K, missed analyst consensus of $885.0K by $188.0K. Diluted EPS came in at $-0.23, beat the $-0.24 consensus by $0.01.
Revenue
$697.0Kmissed by $188.0K
Consensus: $885.0KDiluted EPS
$-0.23beat by $0.01
Consensus: $-0.24
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about Spruce Biosciences, Inc. 's Q4 2024 earnings report.
Spruce Biosciences, Inc. (SPRB) reported Q4 2024 earnings on April 2, 2025 before market open.
Spruce Biosciences, Inc. reported revenue of $697.0K and diluted EPS of $-0.23 for Q4 2024.
Revenue missed the consensus estimate of $885.0K by $188.0K. EPS beat the consensus estimate of $-0.24 by $0.01.